MedPath

The effectiveness of Siddha and Allopathic treatment as reported by clinicians and patients

Not Applicable
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2020/01/022884
Lead Sponsor
Melaka Manipal Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with PASI score >10

2.Patient with Psoriasis Vulgaris (plaque psoriasis) and palmoplantar type of psoriasis

3.Patients with no systemic therapy for the past four weeks or topical therapy for the past two weeks

Exclusion Criteria

1.Pregnant and lactating women

2.Coexisting eczema or lichen planus

3.Patients on any systemic drugs known to exacerbate psoriasis

4.Patients who are on any other treatment for psoriasis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of patients reaching PASI 75 (75% improvement in the PASI score)Timepoint: 0,1,2,3,4 months
Secondary Outcome Measures
NameTimeMethod
umber of relapses in each patient <br/ ><br>Number of patients with different grades of remission <br/ ><br>Time taken to achieve different grades of remission <br/ ><br>Duration of remission <br/ ><br>Assessment of adverse effects <br/ ><br>Improvement in the patient-reported outcomes scoreTimepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath